Efficacy of Intercostal Block Versus Pectoral Nerve Block II
NCT ID: NCT03937076
Last Updated: 2019-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2019-06-01
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the research group, patients with get PECS II block at the end of the surgery and will get a similar postoperative pain control regimen. The investigators hope to find which pain control block is superior.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Intercostal Block Scheduling in Preventing Acute Surgical and Post-surgical Pain in Thoracoscopic Surgery
NCT02469610
Serratus Posterior Superior Intercostal Plane Block, Versus Erector Spinae Facial Plane Blocks
NCT06989372
Comparative Study Between Combined Modified Pectoral Nerve Block (PECSΙΙ) and Transversus Thoracic Plane Block Versus Erector Spinae Plane Block for Post-operative Analgesia Following Breast Surgeries, (randomized Clinical Trial Study)
NCT06783764
Ultrasound Guided Serratus Posterior Superior Intercostal Plane Versus PECS II Block In Breast Surgeries
NCT06936852
Intercostal Nerve Block for Pain Management After Uniportal Video-assisted Thoracoscopic Surgeries
NCT06838026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recently, the use of the pectoral nerve block (Pecs II) has emerged for different chest wall surgeries, which has proved to be helpful. As a consequence,the investigators want to examine the efficiency of this block in the control of postoperative pain after thoracoscopic procedures.
In this prospective comparative study, patients will be randomly classified into two groups. In the control group, patients will get intercostal block at the end of the surgery and after then will be treated by the customary postoperative pain control regimen. This group represents the existent treating policy.
In the research group, patients with get PECS II block at the end of the surgery and will get a similar postoperative pain control regimen.
The follow up will include checking the pain level in the postoperative days, the extent of the pain relief medication until the discharge, and patient evaluation at the first post-discharge inspection.
The study will include 40 patients in each arm, which will be older than 18 years without gender limitations. This study will not include people with special demands.
Main inclusion criteria: patients planned for thoracoscopic procedures in the investigators department, capable of understanding, reading and signing on the consent form.
Main exclusion criteria: re-operation in the early post-operative period, re-operation at the same side, a known allergy to BUPIVACAINE.
In the case of conversion from thoracoscopic to open approach, patients will be expelled from the study.
The block will be performed solely by the surgeon or the anesthesiologist. Follow-up period will include the postoperative hospitalization period until the first post-discharge inspection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
In the research group, patients with get PECS II block at the end of the surgery and will get a similar postoperative pain control regimen.
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intercostal block
patients will get intercostal block at the end of the surgery, control group
No interventions assigned to this group
PECS II block
patients with get PECS II block at the end of the surgery, research group
PECS II block
Pectoral muscles Nerve block for postsurgical pain, PECS II, based on BUPIVACAINE:
Pectoral muscles nerve block is a procedure in which local anesthetic is injected into two sites.
1. between the major and minor pectoral muscles, in order to anesthetize the lateral and medial nerve. This injection is referred to as PECS I block.
2. between the minor pectoral muscle and the anterior serratus muscle, in order to anesthetize the intercostal nerves.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PECS II block
Pectoral muscles Nerve block for postsurgical pain, PECS II, based on BUPIVACAINE:
Pectoral muscles nerve block is a procedure in which local anesthetic is injected into two sites.
1. between the major and minor pectoral muscles, in order to anesthetize the lateral and medial nerve. This injection is referred to as PECS I block.
2. between the minor pectoral muscle and the anterior serratus muscle, in order to anesthetize the intercostal nerves.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18 years of age
* No known allergy to Bupivacaine
* Candidate who can read, understand and sign inform consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carmel Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dan Levy Faber
Senior thoracic surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dan LEVY FABER, MD
Role: PRINCIPAL_INVESTIGATOR
Carmel Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Carmel Medical center
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMC-18-0191-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.